Lilly Asia Ventures and Baidu Ventures helped the drug discovery software provider push its overall funding past the $310m mark.

China-headquartered molecular analytics software provider Insilico Medicine completed a $255m series C round today backed by subsidiaries of pharmaceutical firms Eli Lilly and internet group Baidu. Lilly Asia Ventures and Baidu Ventures joined private equity firm Warburg Pincus, which led the round, and Eight Roads Ventures, a venture capital subsidiary of investment and financial services…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.